• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在开罗大学医院进行的病例对照研究中检测结直肠癌患者血清中的 miR-1246、miR-23a 和 miR-451。

Detection of miR-1246, miR-23a and miR-451 in sera of colorectal carcinoma patients: a case-control study in Cairo University hospital.

机构信息

Clinical and Chemical Pathology Department, Faculty of Medicine, Cairo University.

Family medicine department, Faculty of Medicine, Cairo University.

出版信息

Afr Health Sci. 2020 Sep;20(3):1283-1291. doi: 10.4314/ahs.v20i3.33.

DOI:10.4314/ahs.v20i3.33
PMID:33402976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7751536/
Abstract

BACKGROUND

Colorectal cancer (CRC) has high morbidity and mortality rates. Invasive techniques and other laboratory tests with variable sensitivity and specificity are currently used in diagnosis. Micro ribonucleic acids (miRNAs) have bio vital roles in cell proliferation and apoptosis. Dys-regulation of miRNAs is linked to tumour genesis. The objective of this study was to evaluate the specificity and sensitivity of serum non-invasive biomarkers (micro-RNAs), miR-1246, miR-23a, and miR-451in CRC patients.

METHODS

Peripheral expression of three miRNAs (miR-1246, miR-23a and miR-451) was investigated in sera of 37 CRC Egyptian patients and 30 healthy controls, using quantitative real-time polymerase chain reaction trying to reach the optimal non-invasive combination of miRNAs.

RESULTS

Serum miR-1246 was up-regulated in sera of CRC patients compared to normal controls (fold change = 3.55; P<0.001) and showed 100% sensitivity and 80% specificity in diagnosis of CRC. Serum miR-451 was significantly down-regulated in CRC patients (fold change = -4.86; p= 0.014), whereas, miR-23a was down-regulated but this was not statistically significant.

CONCLUSION

Up-regulation of miR-1246 and down-regulation of miR-451 in the sera of primary CRC Egyptian patients were confirmed with high sensitivity and specificity. Large-scale studies on a wider spectrum of miRNAs in Egyptian CRC patients are needed.

摘要

背景

结直肠癌(CRC)的发病率和死亡率都很高。目前,在诊断中使用了侵入性技术和其他具有可变灵敏度和特异性的实验室检测。微小核糖核酸(miRNAs)在细胞增殖和凋亡中具有重要的生物学作用。miRNAs 的失调与肿瘤发生有关。本研究旨在评估血清非侵入性生物标志物(miRNAs)miR-1246、miR-23a 和 miR-451 在 CRC 患者中的特异性和敏感性。

方法

使用定量实时聚合酶链反应检测 37 例埃及 CRC 患者和 30 例健康对照者血清中三种 miRNA(miR-1246、miR-23a 和 miR-451)的外周表达,试图达到最佳的非侵入性 miRNA 组合。

结果

与正常对照组相比,CRC 患者血清 miR-1246 上调(倍数变化=3.55;P<0.001),对 CRC 的诊断具有 100%的敏感性和 80%的特异性。CRC 患者血清 miR-451 显著下调(倍数变化=-4.86;p=0.014),而 miR-23a 下调但无统计学意义。

结论

原发性埃及 CRC 患者血清中 miR-1246 的上调和 miR-451 的下调得到了证实,具有较高的敏感性和特异性。需要在埃及 CRC 患者中进行更大规模的研究,以研究更广泛的 miRNA 谱。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4baf/7751536/fcf3c6fd31bd/AFHS2003-1283Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4baf/7751536/37ee2a4b5468/AFHS2003-1283Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4baf/7751536/fcf3c6fd31bd/AFHS2003-1283Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4baf/7751536/37ee2a4b5468/AFHS2003-1283Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4baf/7751536/fcf3c6fd31bd/AFHS2003-1283Fig2.jpg

相似文献

1
Detection of miR-1246, miR-23a and miR-451 in sera of colorectal carcinoma patients: a case-control study in Cairo University hospital.在开罗大学医院进行的病例对照研究中检测结直肠癌患者血清中的 miR-1246、miR-23a 和 miR-451。
Afr Health Sci. 2020 Sep;20(3):1283-1291. doi: 10.4314/ahs.v20i3.33.
2
Differential Expression of miR-21, miR-23a, and miR-27a, and Their Diagnostic Significance in Egyptian Colorectal Cancer Patients.miR-21、miR-23a 和 miR-27a 的差异表达及其对埃及结直肠癌患者的诊断意义。
Genet Test Mol Biomarkers. 2020 Dec;24(12):825-834. doi: 10.1089/gtmb.2020.0184. Epub 2020 Dec 7.
3
The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.血浆微小RNA在结直肠癌诊断和风险评估中的潜力。
Int J Clin Exp Pathol. 2015 Jun 1;8(6):7092-101. eCollection 2015.
4
Circulating exosomal microRNAs as biomarkers of colon cancer.循环外泌体微小RNA作为结肠癌的生物标志物
PLoS One. 2014 Apr 4;9(4):e92921. doi: 10.1371/journal.pone.0092921. eCollection 2014.
5
Investigation of MicroRNA-21 Expression Levels in Serum and Stool as a Potential Non-Invasive Biomarker for Diagnosis of Colorectal Cancer.血清和粪便中MicroRNA-21表达水平作为结直肠癌潜在非侵入性生物标志物的研究
Iran Biomed J. 2017 Mar;21(2):106-13. doi: 10.18869/acadpub.ibj.21.2.106. Epub 2016 Jul 19.
6
Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer.三重 microRNA 分类器的潜力:miR-193a-3p、miR-23a 和 miR-338-5p 用于早期检测结直肠癌。
BMC Cancer. 2013 Jun 8;13:280. doi: 10.1186/1471-2407-13-280.
7
Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer.循环血清微小RNA作为结直肠癌的诊断标志物
PLoS One. 2016 May 2;11(5):e0154130. doi: 10.1371/journal.pone.0154130. eCollection 2016.
8
Serum overexpression of miR-301a and miR-23a in patients with colorectal cancer.结直肠癌患者血清中 miR-301a 和 miR-23a 的过表达。
J Chin Med Assoc. 2019 Mar;82(3):215-220. doi: 10.1097/JCMA.0000000000000031.
9
Evaluation of the Plasma Expression Levels of miR-21 and miR-145 as Potential Non-Invasive Biomarkers for Early Detection of Colorectal Cancer.评估血浆中 miR-21 和 miR-145 的表达水平作为结直肠癌早期检测的潜在非侵入性生物标志物。
Asian Pac J Cancer Prev. 2024 Aug 1;25(8):2797-2804. doi: 10.31557/APJCP.2024.25.8.2797.
10
microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.III 期结直肠癌的 microRNA 表达谱:循环 miR-18a 和 miR-29a 作为有前途的生物标志物。
Oncol Rep. 2013 Jul;30(1):320-6. doi: 10.3892/or.2013.2475. Epub 2013 May 15.

引用本文的文献

1
The Role of Epigenetic Biomarkers as Diagnostic, Predictive and Prognostic Factors in Colorectal Cancer.表观遗传生物标志物在结直肠癌中作为诊断、预测和预后因素的作用
Cancers (Basel). 2025 Aug 12;17(16):2632. doi: 10.3390/cancers17162632.
2
Identification and evaluation of metabolic mRNAs and key miRNAs in colorectal cancer liver metastasis.结直肠癌肝转移中代谢性mRNA和关键miRNA的鉴定与评估
Cancer Cell Int. 2025 Jul 16;25(1):265. doi: 10.1186/s12935-025-03903-x.
3
The multifaceted role of microRNAs in colorectal cancer: pathogenesis and therapeutic implications.

本文引用的文献

1
Circulating MiR-210 and MiR-1246 as Potential Biomarkers for Differentiating Hepatocellular Carcinoma from Metastatic Tumors in the Liver.循环中的MiR-210和MiR-1246作为区分肝细胞癌与肝转移瘤的潜在生物标志物
J Med Biochem. 2019 Mar 3;38(2):109-117. doi: 10.2478/jomb-2018-0010. eCollection 2019 Apr.
2
Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer.微小 RNA 作为结直肠癌潜在诊断和预后标志物的相关性。
Int J Mol Sci. 2018 Sep 27;19(10):2944. doi: 10.3390/ijms19102944.
3
MiRNAs as molecular biomarkers in stage II egyptian colorectal cancer patients.
微小RNA在结直肠癌中的多方面作用:发病机制及治疗意义
Noncoding RNA Res. 2025 May 23;14:65-95. doi: 10.1016/j.ncrna.2025.05.012. eCollection 2025 Oct.
4
Assessing circulating miR-1246 as a diagnostic biomarker for colorectal cancer: Insights from a meta-analysis.评估循环miR-1246作为结直肠癌诊断生物标志物:一项荟萃分析的见解
Indian J Gastroenterol. 2025 Jun 11. doi: 10.1007/s12664-025-01805-4.
5
Combinatorial Analysis of miRNAs and tRNA Fragments as Potential Biomarkers for Cancer Patients in Liquid Biopsies.作为液体活检中癌症患者潜在生物标志物的微小RNA和转运RNA片段的组合分析
Noncoding RNA. 2025 Feb 14;11(1):17. doi: 10.3390/ncrna11010017.
6
Advances in microRNAs as Emerging Biomarkers for Colorectal Cancer Early Detection and Diagnosis.微小 RNA 作为结直肠癌早期检测和诊断的新兴生物标志物的研究进展。
Int J Mol Sci. 2024 Oct 15;25(20):11060. doi: 10.3390/ijms252011060.
7
A Systematic Review of Diagnostic Performance of Circulating MicroRNAs in Colorectal Cancer Detection with a Focus on Early-Onset Colorectal Cancer.循环 microRNAs 在结直肠癌检测中的诊断性能的系统评价:重点关注早发性结直肠癌。
Int J Mol Sci. 2024 Sep 3;25(17):9565. doi: 10.3390/ijms25179565.
8
Therapeutic Applications of Stem Cell-Derived Exosomes.干细胞衍生的外泌体的治疗应用。
Int J Mol Sci. 2024 Mar 21;25(6):3562. doi: 10.3390/ijms25063562.
9
Identification of serum miR-1246 and miR-150-5p as novel diagnostic biomarkers for high-grade serous ovarian cancer.鉴定血清 miR-1246 和 miR-150-5p 作为高级别浆液性卵巢癌的新型诊断生物标志物。
Sci Rep. 2023 Nov 7;13(1):19287. doi: 10.1038/s41598-023-45317-7.
10
MicroRNA-nanoparticles against cancer: Opportunities and challenges for personalized medicine.用于抗癌的微小RNA纳米颗粒:个性化医疗的机遇与挑战
Mol Ther Nucleic Acids. 2023 Apr 4;32:371-384. doi: 10.1016/j.omtn.2023.03.021. eCollection 2023 Jun 13.
miRNAs 作为埃及 II 期结直肠癌患者的分子生物标志物。
Exp Mol Pathol. 2018 Dec;105(3):260-271. doi: 10.1016/j.yexmp.2018.09.002. Epub 2018 Sep 10.
4
Potential roles of microRNAs and ROS in colorectal cancer: diagnostic biomarkers and therapeutic targets.微小RNA和活性氧在结直肠癌中的潜在作用:诊断生物标志物和治疗靶点。
Oncotarget. 2017 Mar 7;8(10):17328-17346. doi: 10.18632/oncotarget.14461.
5
Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer.循环血清微小RNA作为结直肠癌的诊断标志物
PLoS One. 2016 May 2;11(5):e0154130. doi: 10.1371/journal.pone.0154130. eCollection 2016.
6
Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation.早期循环微小RNA可预测肝细胞癌患者肝移植后的肿瘤复发及生存情况。
Oncotarget. 2016 Apr 12;7(15):19824-39. doi: 10.18632/oncotarget.7627.
7
Colorectal Cancer Patient Characteristics, Treatment and Survival in Oman--a Single Center Study.阿曼结直肠癌患者的特征、治疗与生存情况——一项单中心研究
Asian Pac J Cancer Prev. 2015;16(12):4853-8. doi: 10.7314/apjcp.2015.16.12.4853.
8
p53-induced microRNA-1246 inhibits the cell growth of human hepatocellular carcinoma cells by targeting NFIB.p53诱导的微小RNA-1246通过靶向NFIB抑制人肝癌细胞的生长。
Oncol Rep. 2015 Mar;33(3):1335-41. doi: 10.3892/or.2015.3715. Epub 2015 Jan 14.
9
Colorectal cancer cell-derived microvesicles containing microRNA-1246 promote angiogenesis by activating Smad 1/5/8 signaling elicited by PML down-regulation in endothelial cells.含有微小RNA - 1246的结肠直肠癌细胞衍生微泡通过激活内皮细胞中由早幼粒细胞白血病蛋白(PML)下调引发的Smad 1/5/8信号传导来促进血管生成。
Biochim Biophys Acta. 2014 Nov;1839(11):1256-72. doi: 10.1016/j.bbagrm.2014.09.002. Epub 2014 Sep 10.
10
The rationality of N3 classification in the 7th edition of the International Union Against Cancer TNM staging system for gastric adenocarcinomas: a case-control study.第 7 版国际抗癌联盟 TNM 分期系统中 N3 分类在胃腺癌中的合理性:一项病例对照研究。
Int J Surg. 2014;12(9):893-6. doi: 10.1016/j.ijsu.2014.06.014. Epub 2014 Jul 12.